Choosing pharmaceutical packaging materials looks like a procurement decision. It isn't. It's a regulatory exercise that decides whether your stability study passes, whether your batch survives transit, and whether the FDA accepts your filing. Picking the wrong material doesn't just cost money. It costs months of qualification work and sometimes the launch.
Glass: the inert default for liquids and injectables
Glass vials, ampoules, and bottles dominate sterile injectables, lyophilized products, and most liquid formulations. The reason: glass is chemically inert. It doesn't react with the product, doesn't leach plasticizers, doesn't change the API's chemistry over shelf life.
The downside is fragility and weight. A glass vial breaks. A glass bottle is heavy to ship. For solid orals where there's no chemistry-with-glass benefit, plastic almost always wins.
Plastics: versatile, cheap, regulated
PVC, PVDC, HDPE, PP, PET. Each has a different barrier profile. Each leaches different amounts of different things over different timescales, which is why USP and Ph. Eur. extractables and leachables testing exists.
- PVC: cheapest, basic moisture barrier, default for most solid orals.
- PVDC-coated PVC: better moisture and oxygen barrier.
- HDPE: standard for OTC bottles. Good moisture barrier, child-resistant caps available.
- PP: tougher, higher heat resistance. Used in some medical device packaging.
- PET: clear, strong, used where presentation matters.
The biological question with plastics is always extractables: what comes out of the polymer over time, into the API. The regulatory question is leachables: do those extractables exceed the safety threshold for the patient. Both have to be characterized for any new pack.
Aluminum: the highest barrier money can buy
Aluminum foil as lidding on a thermoformed blister, or cold-formed Alu-Alu as both forming film and lidding. The barrier numbers are an order of magnitude better than plastic. If your API is hygroscopic, oxygen-sensitive, or light-sensitive, aluminum is what stands between successful stability data and a failed batch.
It costs more. Fine. The cost of an Alu-Alu blister is small compared to the cost of a missed launch.
Paperboard and laminates: the secondary layer
Paperboard cartons and blister wallets aren't usually classed as primary packaging because they don't directly touch the API. But they carry the patient information, the brand, the tamper-evidence band, and the FMD 2D Data Matrix code. The choice is mostly about printability, FSC certification, and recyclability.
All Ecobliss paperboard is FSC-licensed (license C194323). Cold seal wallets pair recyclable paperboard with the blister inside, which gives you both the barrier of plastic-or-aluminum and the recyclability of paper for the visible part.
Pre-filled syringes and specialty containers
For self-administered injectables: glass or polymer pre-filled syringes. The choice is driven by the API (some don't tolerate silicon used in glass syringes), by the patient (a child or arthritic adult might need a polymer syringe with autoinjector), and by cost.
For drug-eluting implants and similar specialty packs, biodegradable polymers and ceramics are entering the mainstream slowly. Mostly research-stage in 2026, with a few approved products.
How to actually pick the right material
From the stability study, top down. The API tells you the barrier requirement. The barrier requirement tells you the material. The material tells you the form factor (blister, bottle, vial, syringe). The form factor tells you the secondary packaging.
Where companies waste time is reverse-engineering this. Picking a form factor first because it looks nice, then trying to make the material fit the stability data. It rarely does. If you want a second opinion on a material decision, send us the stability data and current spec. We'll tell you whether you've got the right material or whether the launch is going to embarrass you.
Request a free sample now!
